LYSARC conducts clinical trials in the field of lymphoma, these studies having a sole academic purpose or also contributing to industrial developments:
- Phase I trials, including first-in-man
- Phase IIa and IIb trials
- Phase III trials, including international pivotal studies aimed at registration
- Phase IV trials on marketed drugs, for monitoring including toxicity
About 50 active or finalized trials are conducted each year by LYSARC, which generally is the sponsor of its studies.
Projects run by LYSARC come from LYSA, The Lymphoma Study Association, cooperative group, international leader of lymphoma research or one of its academic or industrial partners.